TY - JOUR
KW - Antidiabetic
KW - erythema nodosum leprosum
KW - lepra reaction
KW - pharmacology
KW - stress
KW - targets
AU - Thangaraju P
AU - Varthya S
AU - Venkatesan S
AB - <p>A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.</p>
BT - Indian journal of pharmacology
C1 - https://www.ncbi.nlm.nih.gov/pubmed/32874007
DA - 01/2020
DO - 10.4103/ijp.IJP_788_19
IS - 3
J2 - Indian J Pharmacol
LA - eng
N2 - <p>A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.</p>
PY - 2020
SP - 222
EP - 226
T2 - Indian journal of pharmacology
TI - Target/therapies for chronic recurrent erythema nodosum leprosum.
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446680/
VL - 52
SN - 1998-3751
ER -